From: Expression pattern of matrix metalloproteinases in human gynecological cancer cell lines
Cell line | Tissue | Cell type | Origin | Special features | Citation |
---|---|---|---|---|---|
Ishikawa | Endometrium | Adenocarcinoma | Primary tumor | ER positive, PR positive | |
HEC-1-A | Endometrium | Adenocarcinoma | Primary tumor | ER positive PR positive | |
AN3-CA | Endometrium | Adenocarcinoma | Metastatic site (lymph node) | ER positive PR positive | |
HeLa | Cervix | Adenocarcinoma | Primary tumor | HPV-18 positive | |
Caski | Cervix | Epidermoid carcinoma | Metastasis (small bowel mesentery) | HPV-16 positive HPV-18 positive | |
SiHa | Cervix | Squamous cell carcinoma | Primary tumor | HPV-16 positive | |
JEG | Placenta | Chorioncarcinoma | Primary tumor | Produce hCG, HCS, progesterone | |
JAR | Placenta | Chorioncarcinoma | Primary tumor | Produce estrogen, progesterone, hCG, HCS | [38] |
BeWo | Placenta | Chorioncarcinoma | Metastatic site (cerebral metastasis) | Produce estrogen, progesterone, hCG, HCS, estrone, estriol, estradiol, keratin | |
BG_1 | Ovary | Adenocarcinoma | Primary tumor | ER positive PR positive | |
OAW 42 | Ovary | Cystadenocarcinoma | Metastatic site (ascites) | Â | |
PA1 | Ovary | Teratocarcinoma | Metastatic site (ascites) | Â | [45] |